While the majority of subjects exhibited reactivity against the spike protein from both 229E and NL63, persistent COVID-19 symptoms did not statistically impact the magnitude of 229E (Figure 5A) or NL63 (Figure 5B) spike protein reactivity as assessed by IFN-γ ELISPOT. The gene discussed is CHMP5; the disease is COVID-19.